[CAS NO. 1093793-05-5]  PV-1019

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [1093793-05-5]

Catalog
HY-125203
Brand
MCE
CAS
1093793-05-5

DESCRIPTION [1093793-05-5]

Overview

MDL-
Molecular Weight394.39
Molecular FormulaC18H18N8O3
SMILESO=C(C(N1)=CC2=C1C([N+]([O-])=O)=CC=C2)NC3=CC=C(/C(C)=N/NNC(N)=N)C=C3

For research use only. We do not sell to patients.

Summary

PV-1019 (NSC 744039) is a potent, selective Chk2 inhibitor with an IC 50 value of 24 nM. PV-1019 inhibits the Topotecan (HY-13768)-induced Chk2 autophosphorylation. PV-1019 inhibits IR-induced apoptosis [1] .


IC50 & Target

Chk2

24 nM (IC 50 )


In Vitro

PV-1019 (NSC 744039; 0.1-100 μM; 48 h) has antiproliferative effect in human tumor cells [1] .
PV-1019 inhibits Chk2 autophosphorylation and histone H1 phosphorylation with an IC 50 value of 138 nM [1] .
PV-1019 (1-50 μM; 1 h; OVCAR-5 cells) inhibits the Topotecan -induced Chk2 autophosphorylation with an IC 50 value of 2.8 μM [1] .
PV-1019 (1 μM; 16 h) abrogates IR-induced apoptosis in mouse thymocytes [1] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Viability Assay [1]

Cell Line: human tumor cells
Concentration: 0.1-100 μM
Incubation Time: 48 hours
Result: Inhibited cell growth in a dose-dependent manner.

Western Blot Analysis [1]

Cell Line: OVCAR-5 cells
Concentration: 1, 5, 10, and 25 μM
Incubation Time: 1 hours
Result: Decreased the level of Chk2 autophosphorylation (Ser516) in a dose-dependent manner.

Cell Cycle Analysis [1]

Cell Line: mouse thymocytes
Concentration: 1 μM
Incubation Time: 16 hours
Result: Decreased in the sub-G1 fraction (56%).

Shipping

Room temperature in continental US; may vary elsewhere.


Storage

Please store the product under the recommended conditions in the Certificate of Analysis.